Rhythm Pharmaceuticals Inc. Shares Close the Week 20.5% Higher - Weekly Wrap
The company saw its shares close the week 20.5% higher than last week, with trading volume higher than its 30 day average.
Nov 17, 2023 by Kwhen Finance Editors
Rhythm Pharmaceuticals Inc. (RYTM) shares closed this week 20.5% higher than it did at the end of last week. The stock is currently up 11.5% year-to-date, up 26.7% over the past 12 months, and up 13.1% over the past five years. This week, the Dow Jones Industrial Average rose 3.2%, and the S&P 500 rose 3.8%.
Trading Activity
- Shares traded as high as $33.68 and as low as $26.55 this week.
- Trading volume this week was 8.6% lower than the 10-day average and 14.6% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | 2.6 | 11.5 | 26.7 | ||
| Dow Jones Industrial Average | -0.2 | 8.1 | 7.0 | -1.1 | 13.3 |
| S&P 500 Index | 0.1 | 19.9 | 16.5 | -1.3 | 22.3 |
| Health Care | -0.1 | -3.9 | -1.4 | -7.2 | 5.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -135.3%
- The company's stock price performance over the past 12 months beats the peer average by -180.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals Inc. | RYTM | -10.3 | 11.5 | 26.7 | ||
| Peer Avg | N/A | 0 | -32.5 | -33.3 | -18.4 | 0 |
| Omega Therapeutics Inc | OMGA | 0 | -68.0 | -71.2 | ||
| Oncorus Inc | ONCR | 0 | -62.0 | -62.0 | -73.7 | 0 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: